Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER_GOV 2OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Classical hematology 1

Conditions

Prostatic Neoplasms 17Neoplasms 13Breast Neoplasms 12Neuroendocrine Tumors 8Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 7Neoplasm Metastasis 6Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Multiple Myeloma 4Rectal Neoplasms 3Pancreatic Neoplasms 3Mouth Neoplasms 3Lymphoma, Non-Hodgkin 3Glioma 3Esophageal Squamous Cell Carcinoma 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplastic Cells, Circulating 2Nasopharyngeal Carcinoma 2Multiple Pulmonary Nodules 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Liver Neoplasms 2Leukemia 2Hypoxia 2Hematologic Neoplasms 2Head and Neck Neoplasms 2

Interventions

Blood Specimen Collection 9Surveys and Questionnaires 5Magnetic Resonance Spectroscopy 5Biopsy 5Prednisone 4Colonoscopy 4Biopsy, Fine-Needle 4Tomography, X-Ray Computed 3Surgical Procedures, Operative 3Mammography 3Magnetic Resonance Imaging 3Liquid Biopsy 3Lenalidomide 3Interviews as Topic 3Exercise 3Diagnostic Tests, Routine 3Cyclophosphamide 3weifuchun 2pembrolizumab 2obinutuzumab 2Urination 2Preoperative Exercise 2Positron Emission Tomography Computed Tomography 2Observation 2Methods 2Melphalan 2Immunohistochemistry 2Hematologic Tests 2Gemcitabine 2Educational Status 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Disease × Positron Emission Tomography Computed Tomography × Clear all
NCT03429387 2022-05-17

PIPPIN

Peter MacCallum Cancer Centre, Australia

Phase NA Completed
147 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Disease, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT02042053 2017-07-18

PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer

NYU Langone Health

Phase NA Terminated
10 enrolled
Genitourinary

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡